Andrew Gengos - Net Worth and Insider Trading

Andrew Gengos Net Worth

The estimated net worth of Andrew Gengos is at least $73,510 dollars as of 2024-11-05. Andrew Gengos is the CFO and Chief Business Officer of Athira Pharma Inc and owns about 97,532 shares of Athira Pharma Inc (ATHA) stock worth over $73,510. Details can be seen in Andrew Gengos's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Andrew Gengos has not made any transactions after 2024-09-05 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Andrew Gengos

To

Andrew Gengos Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Andrew Gengos owns 4 companies in total, including Synlogic Inc (SYBX) , EOM Pharmaceutical Holdings Inc (IMUC) , and Cyteir Therapeutics Inc (CYTT) among others .

Click here to see the complete history of Andrew Gengos’s form 4 insider trades.

Insider Ownership Summary of Andrew Gengos

Ticker Comapny Transaction Date Type of Owner
SYBX Synlogic Inc 2017-10-09 See Remarks
IMUC EOM Pharmaceutical Holdings Inc 2016-12-31 director
CYTT Cyteir Therapeutics Inc 2021-06-17 Chief Business Officer
LIMIT LIMIT 2024-09-05 See Below

Andrew Gengos Latest Holdings Summary

Andrew Gengos currently owns a total of 1 stock. Andrew Gengos owns 97,532 shares of Athira Pharma Inc (ATHA) as of September 5, 2024, with a value of $73,510.

Latest Holdings of Andrew Gengos

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
ATHA Athira Pharma Inc 2024-09-05 97,532 0.75 73,510

Holding Weightings of Andrew Gengos


Andrew Gengos Form 4 Trading Tracker

According to the SEC Form 4 filings, Andrew Gengos has made a total of 5 transactions in Athira Pharma Inc (ATHA) over the past 5 years, including 2 buys and 3 sells. The most-recent trade in Athira Pharma Inc is the sale of 1,272 shares on September 5, 2024, which brought Andrew Gengos around $725.

Insider Trading History of Andrew Gengos

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Andrew Gengos Trading Performance

GuruFocus tracks the stock performance after each of Andrew Gengos's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Andrew Gengos is -32.75%. GuruFocus also compares Andrew Gengos's trading performance to market benchmark return within the same time period. The performance of stocks bought by Andrew Gengos within 3 months outperforms 0 times out of 2 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Andrew Gengos's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Andrew Gengos

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
0 out of 2 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) -14.55 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) -18.12 LIMIT LIMIT LIMIT LIMIT LIMIT

Andrew Gengos Ownership Network

Ownership Network List of Andrew Gengos

No Data

Ownership Network Relation of Andrew Gengos

Insider Network Chart

Andrew Gengos Owned Company Details

What does Synlogic Inc do?

Who are the key executives at Synlogic Inc?

Andrew Gengos is the See Remarks of Synlogic Inc. Other key executives at Synlogic Inc include Chief Operating Officer Antoine Awad , Chief Financial Officer Michael Vangsted Jensen , and Chief Medical Officer Aoife Brennan .

Synlogic Inc (SYBX) Insider Trades Summary

Over the past 18 months, Andrew Gengos made no insider transaction in Synlogic Inc (SYBX). Other recent insider transactions involving Synlogic Inc (SYBX) include a net sale of 267 shares made by , and a net sale of 372 shares made by Antoine Awad .

In summary, during the past 3 months, insiders sold 79 shares of Synlogic Inc (SYBX) in total and bought 0 shares, with a net sale of 79 shares. During the past 18 months, 639 shares of Synlogic Inc (SYBX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 639 shares.

Synlogic Inc (SYBX)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Synlogic Inc Insider Transactions

No Available Data

Andrew Gengos Mailing Address

Above is the net worth, insider trading, and ownership report for Andrew Gengos. You might contact Andrew Gengos via mailing address: 21900 Burbank Boulevard, 3rd Floor, Woodland Hills Ca 91367.